A robust cd8+ t cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage iii lung adenocarcinoma

HIGHLIGHTS

• who: Jinteng Feng from the Jinan University, China have published the article: A robust CD8+ T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma, in the Journal: (JOURNAL)
• what: Lung cancer has become the first reason of all cancerassociated deaths worldwide, also in China, which accounts f or n e a r l y on e m i ll i o n d e a t h s e a c h y e a r , an d approximately 85% cases are Non-small cell lung cancer . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.